Suppliers / Gopaldas Visram

Gopaldas Visram

India 253 employees Updated 9 July 2026

Gopaldas Visram is a finished-dose manufacturer based in India. It appears in 79 regulatory filings across 4 regulators, without an active US DMF or CEP on file. Its filings concentrate with NAFDAC (NG), FDA (GH) and MINSA (CR). Its GMP standing is certified by NAFDAC (NG), US FDA and FDA (GH). Its most recent recorded inspection, by US FDA, closed on 24 January 2025 as VAI. Customs aggregates show $12.5M of exports covering 903 molecules to 10 destinations in 2025.

0
active US DMFs
0
valid CEPs
3
registered plants 1 with an FDA FEI number
79
filings across 4 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
3 of 3 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.

Inspection history

  • 24 January 2025 VAI US FDA
  • 15 November 2019 VAI US FDA
  • 1 December 2017 VAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Navi Mumbai, India 3009565091
THANE MAHARASHTRA STATE, Nigeria Not on file
Navi Mumbai India, Nigeria Not on file

Filings and GMP by regulator

Regulator Filings GMP certificates
NAFDAC (NG) 30 3
FDA (GH) 17 1
MINSA (CR) 17 None
ARCSA (EC) 15 None
US FDA None 1

Scale

Year Revenue Exports Destinations
2026 YTD Not reported $1.6M 4
2025 Not reported $12.5M 10
2024 Not reported $9.5M 9
2023 Not reported $5.5M 7

Export figures are customs aggregates. We do not publish the identity of any buyer.

Questions about Gopaldas Visram

Does Gopaldas Visram hold a US DMF or a CEP?
No active US drug master file or valid CEP is on record for Gopaldas Visram. It does have 79 filings with 4 regulators, so it is registered, just not with the two strong registers buyers usually screen on.
Is Gopaldas Visram FDA-registered?
One site operated by Gopaldas Visram carries an FDA establishment identifier (FEI), which means it is registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
How did Gopaldas Visram's last inspection go?
The most recent inspection on record closed on 24 January 2025 as VAI (Voluntary Action Indicated: issues were found but did not warrant regulatory action). 3 inspections are on file.
Where does Gopaldas Visram manufacture?
3 registered sites are on record, in India and Nigeria (Navi Mumbai, Thane Maharashtra State and Navi Mumbai India). Every site is listed on this page with the register it came from.
Which regulators recognise Gopaldas Visram's GMP?
Current GMP certificates are on record from NAFDAC (NG), US FDA and FDA (GH). GMP recognition covers the manufacturing site, separately from any filing on the substance itself.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Gopaldas Visram comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was VAI, on 24 January 2025.

Comparable suppliers

Abbott Healthcare also in India Accent Pharmaceuticals Diagnostics also in India Accure Labs Pvt.Ltd also in India ACME Formulation also in India Acme Generics also in India

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates
Customs aggregates
Export values, molecule and destination counts